No Data
No Data
Earnings Preview: TVTX to Report Financial Results Post-market on February 20
Express News | Viking Global Investors' Latest 13F Filing Reveals 897.3K New Share Stake In American Tower, 671.8K Shares In Travelers Companies, 2.58M Shares In General Motors, 1.02M Shares In Aptiv, 5.30M Shares In Snap, 2.90M Shares In Travere Therapeutics,...
Guggenheim Maintains Travere Therapeutic(TVTX.US) With Buy Rating, Raises Target Price to $47
Industry Analysts Just Made A Meaningful Upgrade To Their Travere Therapeutics, Inc. (NASDAQ:TVTX) Revenue Forecasts
Express News | Travere Therapeutics Inc : Guggenheim Raises Target Price to $47 From $45
Travere Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results